NUDGE实用临床试验:提升心血管药物依从性的随机对照试验方案
NUDGE实用临床试验利用药房数据,通过手机短信和人工智能交互聊天机器人向三个整合医疗系统中的患者发送行为助推信息,以改善心血管药物依从性和患者结局。目标随机约10000名参与者至四组:常规护理、通用助推、优化助推、优化助推加AI聊天机器人。主要结局为基于药房续药数据的服药天数比例。
要点
- 基于药房数据通过短信和AI聊天机器人推送行为助推。
- 目标随机约10000名心血管或糖尿病患者至四组。
- 主要结局为药房续药数据计算的服药天数比例。
核心结论
- 该方案旨在利用移动手机技术和人工智能聊天机器人改善心血管药物依从性和患者结局。
研究设计与样本
- 多中心实用随机对照试验,目标随机约10000名参与者至四个研究组。
- 使用mHealth理论、扩展RE-AIM/PRISM和PRECIS-2框架进行规划、实施和评估。
- 纳入标准宽泛,涵盖三个不同医疗系统中服用高血压、房颤、冠心病、糖尿病或高脂血症药物的患者。
主要发现
- PRECIS-2工具显示该研究方案非常实用,但各维度存在差异。
关键数值与推荐
- 主要有效性结局为基于药房续药数据的服药天数比例(PDC)。
- 实施结局采用RE-AIM框架评估,重点关注覆盖度、实施一致性、调整、成本和维持/可持续性。
临床怎么用
- 利用普遍存在的手机技术发送行为助推和AI聊天机器人,以促进心血管药物依从性。
- 基于药房配药数据在人群层面识别和干预,具有可推广性。
局限性
- 检测某些亚组效应的功效有限。
- 对药物并发症(出血)和长期结局(心肌梗死)的评估受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nearly half of patients do not take their cardiovascular medications as prescribed, resulting in increased morbidity, mortality, and healthcare costs. Mobile and digital technologies for health promotion and disease self-management offer an opportunity to adapt behavioral "nudges" using ubiquitous mobile phone technology to facilitate medication adherence. The Nudge pragmatic clinical trial uses population-level pharmacy data to deliver nudges via mobile phone text messaging and an artificial intelligent interactive chat bot with the goal of improving medication adherence and patient outcomes in three integrated healthcare delivery systems. METHODS: The Theory of mHealth, the Expanded RE-AIM/PRISM, and the PRECIS-2 frameworks were used for program planning, implementation, and evaluation, along with a focus on dissemination and cost considerations. During the planning phase, the Nudge study team developed and piloted a technology-based nudge message and chat bot of optimized interactive content libraries for a range of diverse patients. Inclusion criteria are very broad and include patients in one of three diverse health systems who take medications to treat hypertension, atrial fibrillation, coronary artery disease, diabetes, or hyperlipidemia. A target of approximately 10,000 participants will be randomized to one of 4 study arms: usual care (no intervention), generic nudge (text reminder), optimized nudge, and optimized nudge plus interactive AI chat bot. The PRECIS-2 tool indicated that the study protocol is very pragmatic, although there is variability across PRECIS-2 dimensions. DISCUSSION: The primary effectiveness outcome is medication adherence defined by the proportion of days covered (PDC) using pharmacy refill data. Implementation outcomes are assessed using the RE-AIM framework, with a particular focus on reach, consistency of implementation, adaptations, cost, and maintenance/sustainability. The project has limitations including limited power to detect some subgroup effects, medication complications (bleeding), and longer-term outcomes (myocardial infarction). Strengths of the study include the diverse healthcare systems, a feasible and generalizable intervention, transparent reporting using established pragmatic research and implementation science frameworks, strong stakeholder engagement, and planning for dissemination and sustainment. TRIAL REGISTRATION: ClinicalTrials.gov NCT03973931 . Registered on 4 June 2019. The study was funded by the NIH; grant number is 4UH3HL144163-02 issued 4/5/19.
引用
- Glasgow RE, Knoepke CE, Magid D, et al. The NUDGE trial pragmatic trial to enhance cardiovascular medication adherence: study protocol for a randomized controlled trial. Trials. 2021. PMID: 34380527. doi:10.1186/s13063-021-05453-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。